Chemours 4Q Loss Narrows as Volumes Rise

Dow Jones
18 Feb
 

By Dean Seal

 

Chemours recorded a smaller loss in the fourth quarter as refrigerant sales jumped and volumes picked up in two of its business lines.

The Wilmington, Del., chemicals company posted a loss of $8 million, or 5 cents a share, compared with a loss of $18 million, or 12 cents a share, in the same quarter a year ago.

Stripping out one-time items, adjusted earnings were 11 cents a share. That's a penny shy of analyst estimates, according to FactSet.

Sales slipped 1% to $1.36 billion, below analyst forecasts for $1.37 billion, according to FactSet.

The shortfall was driven by a 3% decline in prices, which was partially offset by a 2% increase in volume.

Sales were down slightly in its advanced performance materials business, though volumes were higher from a recent capacity expansion for its Teflon coatings products that more than offset weaker demand in the hydrogen market.

The company's titanium technologies unit saw a small downtick in volumes. Sales in its thermal and specialized solutions business meanwhile rose on a 7% jump in volumes from strong demand for its Opteon Refrigerant blends.

Chemours said it has been working to balance the impact of lower prices with savings from a cost-cutting plan and favorable inventory adjustments.

 

Write to Dean Seal at dean.seal@wsj.com

 

(END) Dow Jones Newswires

February 18, 2025 06:30 ET (11:30 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10